Arrowhead Pharmaceuticals Inc. (ARWR)
NASDAQ · Healthcare
Arrowhead Pharmaceuticals Inc. Shareholder Equity 2011–2025
Arrowhead Pharmaceuticals Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Arrowhead Pharmaceuticals Inc. shareholder equity as of September 30, 2025: 466.1M, a 151.32% increase year-over-year.
- Arrowhead Pharmaceuticals Inc. shareholder equity for 2025 were 466.1M, a 151.32% increase from 2024.
- Arrowhead Pharmaceuticals Inc. shareholder equity for 2024 were 185.4M, a 31.66% decrease from 2023.
- Arrowhead Pharmaceuticals Inc. shareholder equity for 2023 were 271.3M, a 31.91% decrease from 2022.
- Arrowhead Pharmaceuticals Inc. shareholder equity for 2022 were 398.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arrowhead Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $466 |
| 2024 | $185 |
| 2023 | $271 |
| 2022 | $399 |
| 2021 | $409 |
| 2020 | $462 |
| 2019 | $245 |
| 2018 | $96 |
| 2017 | $81 |
| 2016 | $96 |
| 2015 | $110 |
| 2014 | $167 |
| 2013 | $27 |
| 2012 | $10 |
| 2011 | $13 |
Arrowhead Pharmaceuticals Inc. Shareholder Equity — FAQ
Arrowhead Pharmaceuticals Inc. (ARWR) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARWR's shareholder equity history?
The chart and table above show Arrowhead Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.